ACADIA Pharmaceuticals
ACAD
#3678
Rank
โ‚ฌ3.21 B
Marketcap
18,85ย โ‚ฌ
Share price
-0.72%
Change (1 day)
48.79%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): โ‚ฌ0.12 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ1.07 Billion. a decrease over its 2024 earnings that were of โ‚ฌ0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.11 B-46.18%
2024 โ‚ฌ0.22 B-605.67%
2023 -โ‚ฌ43.57 Million-76.09%
2022 -โ‚ฌ0.19 Billion27.41%
2021 -โ‚ฌ0.15 Billion-40.38%
2020 -โ‚ฌ0.24 Billion19.88%
2019 -โ‚ฌ0.21 Billion-3.92%
2018 -โ‚ฌ0.21 Billion-15.04%
2017 -โ‚ฌ0.25 Billion6.33%
2016 -โ‚ฌ0.24 Billion64.55%
2015 -โ‚ฌ0.15 Billion77.47%
2014 -โ‚ฌ78.95 Million143.69%
2013 -โ‚ฌ32.4 Million81.93%
2012 -โ‚ฌ17.81 Million-8.73%
2011 -โ‚ฌ19.51 Million-251.39%
2010 โ‚ฌ12.88 M-133.2%
2009 -โ‚ฌ38.82 Million-30.82%
2008 -โ‚ฌ56.11 Million6.43%
2007 -โ‚ฌ52.73 Million25.89%
2006 -โ‚ฌ41.88 Million36.99%
2005 -โ‚ฌ30.57 Million37.22%
2004 -โ‚ฌ22.28 Million19.96%
2003 -โ‚ฌ18.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.64 B 24,054.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ8.70 B 7,237.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ21.96 B 18,424.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ7.96 B 6,615.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-โ‚ฌ0.11 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-โ‚ฌ32.98 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA